Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 10 hours ago
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course (Bucharest) - October 2026, Hotel Capital Plaza Bucharest, from 29 October 2026, 08:00 (CET) to 30 October 2026, 12:00 (CET)
about 10 hours ago
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course (Bucharest) - October 2026...
Human medicines European public assessment report (EPAR): Ebixa, memantine, Date of authorisation: 15/05/2002, Revision: 27, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Ebixa, memantine, Date of authorisation...
Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 4, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation...
Meeting Summary - PCWP/HCPWP joint meeting
about 11 hours ago
Meeting Summary - PCWP/HCPWP joint meeting
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Mepsevii, vestronidase alfa, Date of authorisation: 23/08/2018, Revision: 9, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Mepsevii, vestronidase alfa, Date of...
Human medicines European public assessment report (EPAR): Tolura, telmisartan, Date of authorisation: 04/06/2010, Revision: 15, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Tolura, telmisartan, Date of authorisation...
Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Date of authorisation: 04/12/2016, Revision: 22, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Date of authorisation...
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation...
Orphan designation: copper metabolism disorder Treatment of Wilson's disease, 20/05/2026 Positive
about 17 hours ago
Orphan designation: copper metabolism disorder Treatment of Wilson's disease, 20/05/2026 Positive
Orphan designation: quemliclustat Treatment of pancreatic cancer, 20/05/2026 Positive
about 17 hours ago
Orphan designation: quemliclustat Treatment of pancreatic cancer, 20/05/2026 Positive
Orphan designation: serabelisib Treatment of PIK3CA related overgrowth spectrum, 20/05/2026 Positive
about 17 hours ago
Orphan designation: serabelisib Treatment of PIK3CA related overgrowth spectrum, 20/05/2026 Positive